# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-22-000663
Filing Date
2022-02-03
Accepted
2022-02-03 17:31:13
Documents
39

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM S-1 AMENDMENT 2 | sunshine_s1a2.htm iXBRL | S-1/A | 1303750
2 | CONSENT TO BE NAMED AS A DIRECTOR NOMINEE | sunshine_ex9901.htm | EX-99.1 | 2424
3 | CONSENT TO BE NAMED AS A DIRECTOR NOMINEE | sunshine_ex9902.htm | EX-99.2 | 2352
4 | FILING FEE TABLE | sunshine_ex107.htm | EX-FILING FEES | 12668
10 | GRAPHIC | image_001.jpg | GRAPHIC | 7392
11 | GRAPHIC | image_007.jpg | GRAPHIC | 11849
12 | GRAPHIC | image_008.jpg | GRAPHIC | 13466
13 | GRAPHIC | image_009.jpg | GRAPHIC | 18576
14 | GRAPHIC | image_010.jpg | GRAPHIC | 9687
| Complete submission text file | 0001683168-22-000663.txt |  | 3540357

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | sbfm-20210930.xsd | EX-101.SCH | 15405
6 | XBRL CALCULATION FILE | sbfm-20210930_cal.xml | EX-101.CAL | 34965
7 | XBRL DEFINITION FILE | sbfm-20210930_def.xml | EX-101.DEF | 77105
8 | XBRL LABEL FILE | sbfm-20210930_lab.xml | EX-101.LAB | 160040
9 | XBRL PRESENTATION FILE | sbfm-20210930_pre.xml | EX-101.PRE | 130704
33 | EXTRACTED XBRL INSTANCE DOCUMENT | sunshine_s1a2_htm.xml | XML | 224531

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-259394 | Film No.: 22589870
SIC: 8731 Services-Commercial Physical & Biological Research